Neurocrine Biosciences Inc (NBIX)
114.00
+2.12
(+1.89%)
USD |
NASDAQ |
Oct 04, 16:00
114.01
+0.01
(+0.01%)
After-Hours: 20:00
Neurocrine Biosciences Shareholders Equity (Annual): 2.232B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.232B |
| December 31, 2022 | 1.708B |
| December 31, 2021 | 1.374B |
| December 31, 2020 | 1.126B |
| December 31, 2019 | 636.90M |
| December 31, 2018 | 480.76M |
| December 31, 2017 | 372.14M |
| December 31, 2016 | 314.88M |
| December 31, 2015 | 424.45M |
| December 31, 2014 | 208.70M |
| December 31, 2013 | 120.41M |
| December 31, 2012 | 154.37M |
| December 31, 2011 | 60.08M |
| December 31, 2010 | 19.34M |
| Date | Value |
|---|---|
| December 31, 2009 | 3.954M |
| December 31, 2008 | 36.77M |
| December 31, 2007 | 118.70M |
| December 31, 2006 | 314.72M |
| December 31, 2005 | 390.10M |
| December 31, 2004 | 393.83M |
| December 31, 2003 | 391.12M |
| December 31, 2002 | 224.25M |
| December 31, 2001 | 310.39M |
| December 31, 2000 | 163.21M |
| December 31, 1999 | 96.40M |
| December 31, 1998 | 72.00M |
| December 31, 1997 | 83.20M |
| December 31, 1996 | 72.80M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
636.90M
Minimum
2019
2.232B
Maximum
2023
1.415B
Average
1.374B
Median
2021
Shareholders Equity (Annual) Benchmarks
| Repligen Corp | 1.971B |
| Bruker Corp | 1.377B |
| Halozyme Therapeutics Inc | 83.81M |
| Integra Lifesciences Holdings Corp | 1.588B |
| Merit Medical Systems Inc | 1.202B |